Mind Medicine (MNMD) Misses Q3 EPS by 50c

Mind Medicine (NASDAQ: MNMD) reported Q3 EPS of ($0.56), $0.50 worse than the analyst estimate of ($0.06).

For earnings history and earnings-related data on Mind Medicine (MNMD) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• JPMorgan Starts Bechtle AG (BC8:GR) (BECTY) at Neutral
• Geberit AG (GEBN:SW) (GBERY) PT Raised to CHF712 at Jefferies